Experienced in Banti's Syndrome

Dr. Robert W. Reindollar

Gastroenterology
1350 S Kings Dr, 
Charlotte, NC 
Accepting New Patients
Offers Telehealth
Experienced in Banti's Syndrome
1350 S Kings Dr, 
Charlotte, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Robert Reindollar is a Gastroenterologist in Charlotte, North Carolina. Dr. Reindollar is rated as an Experienced provider by MediFind in the treatment of Banti's Syndrome. His top areas of expertise are Hepatitis C, Hepatitis, Nonalcoholic Steatohepatitis (NASH), Endoscopy, and Gastrectomy. Dr. Reindollar is currently accepting new patients.

His clinical research consists of co-authoring 8 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gastroenterology
Licenses
Internal Medicine in NC
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

1350 S Kings Dr, Charlotte, NC 28207
Other Locations
1025 Morehead Medical Dr, Ste 300, Charlotte, NC 28204
10650 Park Rd, Ste 480, Charlotte, NC 28210
1585 Forney Creek Pkwy, Ste 2350, Denver, NC 28037
441 McAlister Rd, Lincolnton, NC 28092

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
Enrollment Status: Active_not_recruiting
Publish Date: July 03, 2025
Intervention Type: Drug
Study Drug: HM15211
Study Phase: Phase 2
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)
Enrollment Status: Completed
Publish Date: September 16, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Terminated
Publish Date: November 25, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

8 Total Publications

Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low-dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis.
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low-dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis.
Journal: Journal of viral hepatitis
Published: October 16, 2018
Similar Doctors
Steven L. Zacks
Distinguished in Banti's Syndrome
Dr. Steven L. Zacks
Gastroenterology | Internal Medicine
Distinguished in Banti's Syndrome
Dr. Steven L. Zacks
Gastroenterology | Internal Medicine

Atrium Health Liver Care & Transplant Pineville

10502 Park Road, Suite 110, 
Charlotte, NC 
 (7.3 miles away)
704-667-1550
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Steven Zacks is an Internal Medicine specialist and a Gastroenterologist in Charlotte, North Carolina. Dr. Zacks is rated as a Distinguished provider by MediFind in the treatment of Banti's Syndrome. His top areas of expertise are Visceromegaly, Enlarged Liver, Hepatitis, and Ascites. Dr. Zacks is currently accepting new patients.

Advanced in Banti's Syndrome
Dr. Stephen Stephenson
Gastroenterology
Advanced in Banti's Syndrome
Dr. Stephen Stephenson
Gastroenterology

Carolina Digestive Health Associates PA

1085 Ne Gateway Ct Ne, Suite 280, 
Concord, NC 
 (22.6 miles away)
704-455-9700
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Stephen Stephenson is a Gastroenterologist in Concord, North Carolina. Dr. Stephenson is rated as a Distinguished provider by MediFind in the treatment of Banti's Syndrome. His top areas of expertise are Swallowing Difficulty, Painful Swallowing, Portal Hypertension, Endoscopy, and Gastrectomy.

Advanced in Banti's Syndrome
Dr. Glen Portwood
Gastroenterology
Advanced in Banti's Syndrome
Dr. Glen Portwood
Gastroenterology

Carolina Digestive Health Associates PA

300 Billingsley Rd, Suite 200, 
Charlotte, NC 
 (1.7 miles away)
704-372-7974
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Glen Portwood is a Gastroenterologist in Charlotte, North Carolina. Dr. Portwood is rated as a Distinguished provider by MediFind in the treatment of Banti's Syndrome. His top areas of expertise are Hiatal Hernia, Congenital Diaphragmatic Hernia, Esophagitis, Gastrectomy, and Colonoscopy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Reindollar's expertise for a condition
ConditionClose
    View All 45 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile